Assessing the Cognitive Benefits of Ozanimod and Their Brain-Biomarkers in MS
Clinical trial NCT06334094 · WITHDRAWN
Trial details
- NCT number
- NCT06334094
- Sponsor
- The University of Texas at Dallas
- Status
- WITHDRAWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-01
- Primary completion
- 2028-03-31
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.